Harbin Pharmaceutical Group Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Harbin Pharmaceutical Group Company Limited with three other
companies in this sector in China:
Sichuan Languang Development Co Ltd
sales of 16.74 billion Chinese Renmimbi [US$2.47 billion]
of which 100%
was Real Estate Development & Management),
Tasly Pharmaceutical Group Company Limited
(13.22 billion Chinese Renmimbi [US$1.95 billion]
of which 51%
was Medicine Commerce), and
Guangzhou Baiyunshan Pharmceutical Holdings Co Ltd
(19.12 billion Chinese Renmimbi [US$2.83 billion]
of which 41%
Harbin Pharmaceutical Group Company Limited reported sales of 15.85 billion Chinese Renmimbi (US$2.34 billion)
December of 2015.
decrease of 3.9%
versus 2014, when the company's sales were 16.50 billion Chinese Renmimbi.